EPCAM and Patent ductus arteriosus: Increased expression of cancer stem cell (CSC) markers, including c-Met, CD133, CD44, EpCAM (also known as ESA), ALDH1, Nanog, Oct4 and SOX2, has been identified in PDA [7, 8].